Beyond its role as tumor suppressor, Ng et al. (2010) reported that the exome sequencing of patients with Kabuki syndrome revealed loss of function mutations in the KMT2D gene, linking these mutations to the development of the syndrome (Ng et al., 2010). The gene discussed is KMT2D; the disease is Kabuki syndrome.